Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1117-1123, February 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munn, D. H.
Right arrow Articles by Cheung, N.-K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munn, D. H.
Right arrow Articles by Cheung, N.-K. V.

Role of Low-Affinity Fc Receptors in Antibody-dependent Tumor Cell Phagocytosis by Human Monocyte-derived Macrophages1

David H. Munn2, Mary McBride and Nai-Kong V. Cheung3

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Human monocyte-derived macrophages (MDM) mediate efficient antibody-dependent cellular cytotoxicity (ADCC) against a variety of human tumor cell types in the presence of an anti-tumor monoclonal antibody. We have recently shown that the mechanism of this ADCC in our in vitro system involves phagocytosis of intact tumor cells. Some forms of macrophage ADCC have been reported to be inhibited by serum immunoglobulin, which competes with monoclonal antibodies for binding to the high-affinity Fc receptor (FcRI). In this study we investigated the role of the three macrophage FcR-{gamma} in antibody-dependent tumor cell phagocytosis. Hybridoma cells bearing surface antibody directed against either of the two low-affinity Fc receptors (FcRII or FcRIII) were efficiently phagocytosed by MDM, compared to hybridomas bearing irrelevant antibody. Soluble anti-receptor antibodies against FcRII and FcRIII were able to inhibit ADCC but only when both antibodies were simultaneously present. These data suggest that either low-affinity Fc receptor is capable of functioning independently to mediate phagocytosis of tumor cells. Consistent with a mechanism involving the low-affinity receptors rather than FcRI, antibody-dependent phagocytosis occurred in the presence of human serum, purified human IgG, and irrelevant murine antibody. Greater than 75% of the MDM in our culture system were able to ingest tumor cells when a suitable target was available. Optimal phagocytosis occurred at monoclonal antibody concentrations of 10–100 ng/ml. Like other forms of macrophage phagocytosis, ingestion of tumor cells required the presence of divalent cations (either Ca2+ or Mg2+) and an intact actin cytoskeleton (as indicated by sensitivity to cytochalasin D). Because FcRI is normally occupied in vivo by serum immunoglobulin, the participation of low-affinity FcR in tumor cell phagocytosis is potentially important in establishing the in vivo applicability of this efficient form of cytotoxicity.

1 Supported in part by National Institutes of Health Grant CA-33049; American Cancer Society Grant IM521; the Friends of Children Foundation, Toys-R-Us Foundation, Inc.; and the Robert Steel Foundation.

2 Current address: Division of Pediatric Hematology-Oncology, Medical College of Georgia, Augusta, GA 30912.

3 To whom requests for reprints should be addressed, at Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

Received 11/ 2/90. Accepted 12/ 4/90.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
J. O. Richards, S. Karki, G. A. Lazar, H. Chen, W. Dang, and J. R. Desjarlais
Optimization of antibody binding to Fc{gamma}RIIa enhances macrophage phagocytosis of tumor cells
Mol. Cancer Ther., August 1, 2008; 7(8): 2517 - 2527.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. O. Gordon and R. S. Freedman
Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients
Clin. Cancer Res., March 1, 2006; 12(5): 1515 - 1524.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. B. van Spriel, J. H. W. Leusen, M. van Egmond, H. B. P. M. Dijkman, K. J. M. Assmann, T. N. Mayadas, and J. G. J. van de Winkel
Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation
Blood, April 15, 2001; 97(8): 2478 - 2486.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Odin, J. Edberg, C. Painter, R. Kimberly, and J. Unkeless
Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor
Science, December 20, 1991; 254(5039): 1785 - 1788.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.